Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Synergistic Photodynamic–Photothermal Tumor Therapy Enabled by NIR-II AIE Nanoparticles — Liang Hao (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Synergistic Photodynamic–Photothermal Tumor Therapy Enabled by NIR-II AIE Nanoparticles
BT
Shared by
Ben Zhong Tang
Synergistic Photodynamic–Photothermal Tumor Therapy Enabled by NIR-II AIE Nanoparticles
Article
2025
Authors
+4 more
LH
Liang Hao
TL
Tianyu Li
SL
Shuhe Liu
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Preprint
2021
AIE nanoparticles camouflaged with tumor cell-derived exosomes for NIR-II imaging-guided photothermal therapy
Yirun Li
,
Xiaoxiao Fan
,
Yuanyuan Li
,
Runze Chen
,
Huwei Ni
,
Yiyin Zhang
,
Qiming Xia
,
Zhe Feng
,
Ben Zhong Tang
,
Jun Qian
,
Hui Lin
Article
2021
Biologically excretable AIE nanoparticles wear tumor cell-derived “exosome caps” for efficient NIR-II fluorescence imaging-guided photothermal therapy
Yirun Li
,
Xiaoxiao Fan
,
Yuanyuan Li
,
Liang Zhu
,
Runze Chen
,
Yiyin Zhang
,
Huwei Ni
,
Qiming Xia
,
Zhe Feng
,
Ben Zhong Tang
,
Jun Qian
,
Hui Lin
Article
2025
Stimulus-responsive AIE nanoassembly for NIR-II imaging-guided cascade photothermal/photodynamic/gas synergistic thrombolysis and vascular healing
Dan Zhou
,
Jialin Tong
,
Liping Zhang
,
Yaxuan Yao
,
Yiting Gao
,
Yachao Wang
,
Gelin Xu
,
Guo‐Gang Shan
,
Lijie Ren
,
Ben Zhong Tang
Article
2023
Efficient NIR-II Type-I AIE Photosensitizer for Mitochondria-Targeted Photodynamic Therapy through Synergistic Apoptosis–Ferroptosis
Jiabao Zhuang
,
Bing Wang
,
Huan Chen
,
Keyi Zhang
,
Nan Li
,
Na Zhao
,
Ben Zhong Tang
Article
2024
NIR‐II AIE Liposomes for Boosting Type‐I Photodynamic and Mild‐Temperature Photothermal Therapy in Breast Cancer Treatment
Shijie Zhen
,
Zhe Xu
,
Meng Suo
,
Teng Zhang
,
Teng Zhang
,
Meng Lyu
,
Tianwei Li
,
Meijing Li
,
Zujin Zhao
,
Ben Zhong Tang
Discussion(0)
No comments yet. Be the first to comment.